Embecta Corp

EMBC · NASDAQ · Healthcare / Medical Instruments & Supplies

6.46USD+0.03 (+0.47%)

Price History

Full chart

Market Stats

Previous Close6.43

Open6.46

Day Range6.16 – 6.50

52-Week Range2.76 – 14.43

Volume566.84K

Market Cap318.43M

P/E (TTM)3.80

Forward P/E0.00

EPS1.48

Dividend Yield0.71%

Beta0.85

50-Day Avg4.65

200-Day Avg7.20

About

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Devdatt Kurdikar Ph.D.
Employees1.85K
Headquarters300 Kimball Drive, Parsippany, NJ, United States, 07054, USA
Websitehttps://www.embecta.com

Leadership

Mr. Devdatt Kurdikar Ph.D.President, CEO & Chairman · b. 1969
Mr. Jacob P. ElguiczeSenior VP & CFO · b. 1973
Mr. Jeffrey Z. MannSenior VP, General Counsel, Head of Business Development & Corporate Secretary · b. 1972
Ms. Jean M. CasnerSenior VP & Chief Human Resources Officer · b. 1958
Mr. Shaun CurtisSenior Vice President of Global Manufacturing & Supply Chain · b. 1970
Mr. Anthony M. RothVP, Chief Accounting Officer & Corporate Controller · b. 1973
Mr. Pravesh KhandelwalVP & Head of Investor Relations
Ms. Ginny BlockiSenior Vice President of Strategy
Mr. Tom BlountSenior VP & President of North America · b. 1974
Mr. Slobodan RadumiloSenior VP & President of International · b. 1971

Financials

Income Statement

Currency: USD	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	1.11B	1.09B	1.17B	1.13B	1.12B	1.12B	1.08B
Growth (%)	-	-2.12%	+7.32%	-3.05%	-0.77%	+0.21%	-3.80%
Cost of Revenue	323.00M	323.00M	365.00M	354.60M	370.90M	394.20M	400.90M
Gross Profit	786.00M	763.00M	800.00M	774.90M	749.90M	728.90M	679.50M
Gross Margin	70.87%	70.29%	68.67%	68.61%	66.91%	64.90%	62.89%
Operating Expense	284.00M	276.00M	308.00M	396.80M	520.30M	554.70M	350.20M
Operating Income	502.00M	487.00M	492.00M	378.10M	229.60M	174.20M	329.30M
Operating Margin	45.27%	44.86%	42.23%	33.47%	20.49%	15.51%	30.48%
EBITDA	536.00M	524.00M	533.00M	334.50M	245.40M	199.00M	294.70M
EBITDA Margin	48.33%	48.27%	45.75%	29.61%	21.90%	17.72%	27.28%
Net Income	432.00M	427.60M	414.80M	223.60M	70.40M	78.30M	95.40M
Net Income Margin	38.95%	39.39%	35.61%	19.80%	6.28%	6.97%	8.83%
R&D	62.00M	61.00M	63.00M	65.00M	85.20M	78.80M	21.50M
R&D as % of Total Revenue	5.59%	5.62%	5.41%	5.75%	7.60%	7.02%	1.99%
Interest Expense	2.00M	0	3.00M	46.20M	107.00M	112.30M	107.30M
Interest Expense % of Total Revenue	0.18%	0.00%	0.26%	4.09%	9.55%	10.00%	9.93%

Balance Sheet

Currency: USD	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	745.00M	738.00M	788.00M	1.09B	1.21B	1.29B	1.09B
Total Liabilities	126.00M	166.00M	194.00M	1.98B	2.04B	2.02B	1.74B
Total Equity	577.00M	572.00M	594.00M	-891.40M	-821.70M	-738.30M	-651.20M
Cash	-	-	0	330.90M	326.30M	267.50M	225.50M
Total Debt	-	5.00M	4.10M	1.64B	1.64B	1.61B	1.43B
Net Debt	-	5.00M	4.10M	1.31B	1.31B	1.34B	1.20B

Cash Flow

Currency: USD	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	505.00M	498.50M	456.00M	412.20M	67.70M	35.70M	191.70M
Investing Cash Flow	-69.00M	-41.90M	-39.00M	-24.00M	-26.50M	-15.80M	-9.30M
Financing Cash Flow	-436.00M	-456.60M	-417.00M	-48.00M	-48.70M	-73.40M	-226.70M
Capital Expenditure	69.00M	41.90M	39.00M	24.00M	26.50M	15.80M	9.30M
Free Cash Flow	436.00M	456.60M	417.00M	388.20M	41.20M	19.90M	182.40M
Dividends Paid	8.60M	8.60M	8.60M	8.60M	34.40M	34.50M	35.00M
FCF to OCF	86.34%	91.59%	91.45%	94.18%	60.86%	55.74%	95.15%
Dividend Paid to FCF	1.97%	1.88%	2.06%	2.22%	83.50%	173.37%	19.19%

Earnings

Report Date	Mar 16, 2022	May 13, 2022	Aug 15, 2022	Dec 20, 2022	Feb 14, 2023	May 12, 2023	Aug 8, 2023	Nov 21, 2023	Feb 9, 2024	May 9, 2024	Aug 9, 2024	Nov 19, 2024	Feb 6, 2025	May 9, 2025	Aug 8, 2025	Nov 25, 2025	Feb 5, 2026	May 5, 2026	Aug 7, 2026
EPS Estimate	0.00	-	0.87	0.67	0.52	0.48	0.46	0.40	0.46	0.40	0.46	0.36	0.44	0.59	0.78	0.46	0.67	0.42	0.26
EPS Actual	7.17	1.38	1.21	1.18	0.96	0.75	0.69	0.59	0.61	0.67	0.74	0.45	0.65	0.70	1.12	0.50	0.71	0.27	0.56
Surprise	-	-	39.08%	76.12%	84.62%	56.25%	50.00%	47.50%	32.61%	67.50%	60.87%	25.00%	47.73%	18.64%	43.59%	8.70%	5.97%	-35.71%	115.38%
Timing	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap318.43M

Enterprise Value1.59B

Trailing P/E3.80

Forward P/E0.00

Price / Sales0.31

Price / Book2.61

EPS1.48

Book Value-10.81

Revenue (TTM)1.02B

Gross Profit (TTM)595.10M

EBITDA281.50M

Profit Margin8.59%

Operating Margin23.67%

Return on Equity0.00%

Return on Assets12.24%

Shares Outstanding56.66M

Shares Float54.77M

Beta0.85

Dividend Yield0.71%

Dividend Rate0.04

Payout Ratio15.69%

Analyst Ratings

Hold

Based on 5 analystsTarget 4.00

Strong Buy
1
Hold
3
Sell
1

Ownership Breakdown

Institutions: 91.41%
Insiders: 2.01%
Retail / Other: 6.58%

Top Institutional Holders

BlackRock Inc
9.17M16.18%
Yacktman Asset Management Co
4.32M7.62%
Vanguard Capital Management, LLC
2.56M4.53%
State Street Corp
2.55M4.49%
Deerfield Management Co
2.53M4.47%
Jefferies Financial Group Inc
2.36M4.16%
Vanguard Portfolio Management, LLC
1.54M2.71%
Brigade Capital Management LP
1.52M2.68%
Geode Capital Management, LLC
1.47M2.59%
Charles Schwab Investment Management Inc
1.19M2.10%
Krensavage Asset Management, LLC
1.14M2.00%
SG Americas Securities, LLC
1.04M1.83%
Rubric Capital Management LP
1.04M1.83%
Millennium Management LLC
945.97K1.67%
Bank of New York Mellon Corp
823.79K1.45%
Ameriprise Financial Inc
799.69K1.41%

Top Fund Holders

AMG Yacktman I
3.50M6.18%
Vanguard MStar Total Stk Mkt Idx Invest
1.83M3.23%
iShares Russell 2000 ETF
1.61M2.84%
Columbia Small Cap Value Discv A
1.36M2.40%

Dividends

20263×

0.01Aug 27, 20260.01May 28, 20260.15Feb 27, 2026

20254×

0.15Dec 5, 20250.15Aug 29, 20250.15May 28, 20250.15Feb 28, 2025

20244×

0.15Dec 6, 20240.15Aug 27, 20240.15May 28, 20240.15Feb 27, 2024

20234×

0.15Dec 1, 20230.15Aug 24, 20230.15May 25, 20230.15Feb 24, 2023

20222×

0.15Dec 29, 20220.15Aug 25, 2022